Imcyse Reports Positive Immune Response from Interim Analysis of Phase 2 IMPACT Type 1 Diabetes Study
Positive interim biomarker data supports specific immune signature induced by IMCY-0098 and effect on potentially pathogenic T cells Enrollment on...